Company Filing History:
Years Active: 2022
Title: Guo-Chuan Emil Tsai: Innovator in Co-Crystal Technology
Introduction
Guo-Chuan Emil Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical compositions through his innovative work on co-crystals and eutectic crystals. His research focuses on enhancing the physical properties of kojic acid, which has various applications in health and medicine.
Latest Patents
Tsai holds a patent for a novel co-crystal and/or eutectic crystal of kojic acid. This patent includes compositions comprising the co-crystal, processes for producing it, and its uses. The invention provides co-crystals of kojic acid combined with co-formers such as maltol or ethyl maltol. Additionally, it describes a eutectic mixture of kojic acid with co-formers like methyl paraben and propyl gallate. These novel crystals are intended for use in pharmaceutical compositions, health food products, or medical food products aimed at treating or preventing neuropsychiatric disorders.
Career Highlights
Guo-Chuan Emil Tsai is associated with Syneurx International Corp., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the innovation of co-crystal technology, contributing to the improvement of therapeutic options in the medical field.
Collaborations
Tsai collaborates with esteemed colleagues, including Ching-Cheng Wang and Tien-Lan Hsieh. Their combined expertise enhances the research and development initiatives at Syneurx International Corp.
Conclusion
Guo-Chuan Emil Tsai's innovative work in co-crystal technology represents a significant advancement in pharmaceutical science. His contributions are paving the way for new treatments and improving health outcomes for patients.